Cargando…

Pregnancy Outcomes Associated With Biologic Agent Exposure in Patients With Several Rheumatic Diseases and Inflammatory Bowel Diseases

BACKGROUND: This study aimed to analyze pregnancy outcomes based on biologic agents use in women using the nationwide population-based database. METHODS: The study used the claims database to identify women of childbearing age with several rheumatic (rheumatoid arthritis, juvenile idiopathic arthrit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Soo Min, Joo, Young Bin, Kim, Yun Jin, Bang, So-Young, Lee, Hye-Soon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244022/ https://www.ncbi.nlm.nih.gov/pubmed/37272561 http://dx.doi.org/10.3346/jkms.2023.38.e172

Ejemplares similares

Higher Morbidity of Monogenic Inflammatory Bowel Disease Compared to the Adolescent Onset Inflammatory Bowel Disease
por: Kim, Kwang Yeon, et al.
Publicado: (2018)

Role of Biologic Therapies in the Rheumatic Manifestations of Inflammatory Bowel Disease: A Systematic Analysis
por: Nag, Aiswarya, et al.
Publicado: (2023)

Ophthalmologic manifestations in patients with inflammatory bowel disease
por: Lee, Hye Jin, et al.
Publicado: (2017)

Use of Biologic Agents in Ocular Manifestations of Rheumatic Disease
por: Kraus, Courtney L., et al.
Publicado: (2012)

Treatment with biologics during pregnancy in patients with rheumatic diseases
por: Förger, Frauke
Publicado: (2017)

Biologic agents in inflammatory bowel disease – quality of internet website information
por: Rofaiel, Rymon, et al.
Publicado: (2018)

Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease
por: Crouwel, Femke, et al.
Publicado: (2022)

Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics
por: Huh, Gunn, et al.
Publicado: (2019)

Role of inflammasomes in inflammatory autoimmune rheumatic diseases
por: Yi, Young-Su
Publicado: (2018)

Digestive Agents in Inflammatory Rheumatism
por: Swentningen, S. V.
Publicado: (1881)

Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?
por: Park, Jihye
Publicado: (2022)

Pharmacogenetics of Biological Agents Used in Inflammatory Bowel Disease: A Systematic Review
por: Lauro, Rita, et al.
Publicado: (2021)

Various Forms of Tuberculosis in Patients with Inflammatory Bowel Diseases Treated with Biological Agents
por: Krusiński, Adam, et al.
Publicado: (2021)

The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease
por: Seo, Yu Bin, et al.
Publicado: (2020)

Correction: Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics
por: Huh, Gunn, et al.
Publicado: (2019)

PReS13-SPK-1579: Biologic agents for the treatment of rheumatic diseases
por: Emery, P
Publicado: (2013)

Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
por: Santos, Cristiana Sieiro, et al.
Publicado: (2021)

Rheumatic manifestations of inflammatory bowel diseases: A study from the Middle East
por: Hammoudeh, Mohammed, et al.
Publicado: (2018)

Natural Products as a Source of Anti-Inflammatory Agents Associated with Inflammatory Bowel Disease
por: Debnath, Trishna, et al.
Publicado: (2013)

Rheumatic Heart Disease in Pregnancy
por: McKeown, Florence
Publicado: (1950)

Biological and Methotrexate Survival after Pregnancy in Patients With a Rheumatic Disease
por: Tahmasian, Helena, et al.
Publicado: (2022)

Macrophage activation syndrome in rheumatic disease: Clinical characteristics and prognosis of 20 adult patients
por: Nam, So Hye, et al.
Publicado: (2022)

Immunogenicity of biologics in inflammatory bowel disease
por: Vermeire, Séverine, et al.
Publicado: (2018)

A medicoeconomic review of early intervention with biologic agents in the treatment of inflammatory bowel diseases
por: Odes, Shmuel, et al.
Publicado: (2014)

Access to High-Cost Biological Agents: Perceptions of Brazilian Patients with Inflammatory Bowel Diseases
por: Parra, Rogerio Serafim, et al.
Publicado: (2023)

Natural Product-Derived Drugs for the Treatment of Inflammatory Bowel Diseases
por: Joo, Young-Eun
Publicado: (2014)

Current status of image-enhanced endoscopy in inflammatory bowel disease
por: Yang, Young Joo
Publicado: (2023)

The Influence of Corticosteroids, Immunosuppressants and Biologics on Patients With Inflammatory Bowel Diseases, Psoriasis and Rheumatic Diseases in the Era of COVID-19: A Review of Current Evidence
por: Zhang, Mengyuan, et al.
Publicado: (2021)

Modulatory Effects of Pregnancy on Inflammatory Bowel Disease
por: van der Giessen, Janine, et al.
Publicado: (2019)

Insights into the treatment of inflammatory bowel disease in pregnancy
por: Shannahan, Sarah E., et al.
Publicado: (2019)

Tuberculosis in children and adolescents with rheumatic diseases using biologic agents: an integrative review
por: Lima, Lenita de Melo, et al.
Publicado: (2023)

Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease
por: Na, Soo-Young, et al.
Publicado: (2019)

Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs
por: Na, Soo-Young, et al.
Publicado: (2022)

Biological markers of disease activity in inflammatory bowel diseases
por: Szymanska, Edyta, et al.
Publicado: (2023)

Capsule Endoscopy in Inflammatory Bowel Disease: When? To Whom?
por: Na, Soo-Young, et al.
Publicado: (2021)

Immunomics in inflammatory rheumatic diseases
por: Konthur, Z, et al.
Publicado: (2004)

Is Acute Rheumatism an Inflammatory Disease?
por: Craig, T. E.
Publicado: (1889)

Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu
por: García, María José, et al.
Publicado: (2021)

Biologic targeting in the treatment of inflammatory bowel diseases
por: Bosani, Matteo, et al.
Publicado: (2009)

Biologic Concentration Testing in Inflammatory Bowel Disease
por: Vaughn, Byron P., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j7200rhe0htdfskpom2fg7oo8q